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Conclusion: PORT for tongue cancer without intraoral stent is 
best planned with the target volume extending towards the 
palate to allow for inter-fractional movement of the tongue. 
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Purpose or Objective: Anatomical changes taking place over 
the course of radiation therapy (RT) result in a difference 
between planned and delivered dose. For pancreatic cancer, 
we investigated the robustness of clinical treatment plans by 
quantifying the dosimetric effects of changes in gas volumes, 
body contour and interfractional target displacement. In 
addition, we compared the dosimetric effect of anatomical 
changes between use of bony anatomy and use of 
intratumoral fiducial markers for patient positioning. 
 
Material and Methods: Nine pancreatic cancer patients were 
included who had intratumoral markers for daily cone-beam 
CT (CBCT)-based position verification. The clinical plans (10 
MV; 1 arc VMAT; internal CTV (iCTV) to PTV margin = 10 mm) 
were used for dose calculation. To enable fraction dose 
calculations on CBCT, the planning CT was deformably 
registered to each CBCT (13–15 CBCTs per patient); air 
volumes visible on the CBCT were copied to the deformed 
CT.  
Calculations were done for marker-based registration (as 
clinically used) and for bony anatomy-based registration. For 
both methods, doses were rigidly summed to yield the 
accumulated doses on the planning CT. For each patient, all 
DVHs were normalized to yield for the planned dose to the 
PTV: V98% = 95% (100% = 36 Gy).  
To evaluate target coverage, we defined an iCTV+5mm 
volume, i.e. the iCTV expanded with a 5 mm margin to 
account for remaining uncertainties including delineation. We 
analysed D98%, Dmean and D2% for iCTV+5mm and iCTV and 
examined DVH differences for duodenum and stomach, the 
organs at risk closest to the iCTV. 
 
Results: For the iCTV+5mm, D98% changed from mean 96.3% 
(range 95.5–97.8%) for the planned dose to 96.7% (96.4–
97.0%) for marker-based accumulated dose (Table 1).  
 
 
 
These relatively small differences indicate a limited 
dosimetric effect from changes in gas and body contour, even 
though the amount of gas visible on CBCT showed large 
variations (avg. 166 ml, SD 145 ml).  
In contrast, D98% decreased to 95.3% (85.8–97.9%) for bony 
anatomy registration, due to systematic errors inherently 
associated with bony-anatomy patient positioning. Changes 
for stomach and duodenum depended strongly on the 
direction of these errors, with large increases in D2% for 
some (error in direction of organ) and large decreases for 
others. Differences were largest for the stomach (e.g. D2% 
from 72.7% (planned) to 82.4% (bony anatomy-based 
accumulated)). For marker-based positioning, the dosimetric 
effects for stomach and duodenum were limited (<0.5 Gy in 8 
out of 9 patients). 
 
Conclusion: Photon irradiation of pancreatic tumours is 
robust to variations in body contour and gastrointestinal gas, 
with dose coverage only mildly affected by these anatomical 
changes. However, when using bony anatomy for patient 
positioning, dose coverage declines due to interfractional 
tumour position variations. Therefore, the use of fiducial 
marker-based daily position verification is essential in RT for 
pancreatic cancer. 
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Purpose or Objective: Patients undergoing prostate intensity 
modulated arc therapy (IMAT) were retrospectively 
investigated using the CBCT images acquired for setup 
purposes to determine the volumetric variability of the target 
and organs at risk and the dosimetric implications of these 
changes. 
 
Material and Methods: IMAT plans from 11 patients were 
designed to deliver 74 Gy in 37 fractions to the target. The 
CTV consisted of the prostate and seminal vesicles, while the 
PTV was the CTV plus a margin of 10 mm in all directions 
except posteriorly, where a 5 mm margin was used. For 
between 9 and 14 of the 37 fractions, the patients were 
scanned using an on-board CBCT imager to verify the setup. 
These images were retrospectively registered to the planning 
CT using an in-house registration algorithm to determine the 
transformations between the images. The calculated 
transformation vector field was used to deform the planning 
CT so that the plan could be recalculated with the original 
MU on this new adapted CT. This allowed the determination 
of the dosimetric impact of the change in anatomical 
information from the time of acquisition of the planning CT 
to immediately prior to a given treatment fraction. The 
imaged fractions were treated as though they were 
representative of the entire treatment and were weighted 
equally for dose accumulation purposes. 
 
Results: Over the course of the patients’ treatments, the 
changes in CTV volume compared to the plan were from a 
decrease of 25% up to a maximum increase of 6%. Their 
bladder volumes ranged from -10% to 10% of their respective 
volumes on the planning CT. The rectal volume decreased for 
all patients, with 5% less than the planning volume the 
smallest reduction and 34% being the largest volume 
shrinkage. 
The dosimetric impact of these anatomical changes varied for 
each structure. The minimum dose received by the CTV 
varied by less than 1% for all patients, with full coverage of 
the CTV achieved in all fractions. 
The mean dose delivered to the bladder averaged over each 
patients treatment resulted in variation of between -4% and 
17% of their respective planned mean doses. This did not 
result in a break of the dose-volume constraints (DVCs) for 
the bladder at any fraction, for any patient. 
The rectum received a higher mean dose than the planned 
value for all patients. This ranged from an increase of 7% up 
to 38%. It was found that the rectum frequently broke 
multiple DVCs, resulting in the rectum being overdosed in 
79% of the fractions examined. 
 
Conclusion: Analysis of the anatomical condition of the 
patient on the day of treatment can give an indication of how 
suitable the original plan for their treatment is. For these 
patients, although the variability in the anatomy did not 
